125 related articles for article (PubMed ID: 580531)
21. Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix.
Tavaniotou A; Albano C; Smitz J; Devroey P
Hum Reprod; 2001 Apr; 16(4):663-7. PubMed ID: 11278214
[TBL] [Abstract][Full Text] [Related]
22. Human chorionic gonadotropin in intrauterine device users.
Shalit A; Jaschevatzky OE; Kampf D; Leiserowitz DM; Grünstein S
Int J Fertil; 1980; 25(2):134-6. PubMed ID: 6117529
[TBL] [Abstract][Full Text] [Related]
23. Differential responses to a simulated implantation signal at various stages of the luteal phase in women.
Woodward AJ; Lenton EA
J Clin Endocrinol Metab; 1992 May; 74(5):999-1004. PubMed ID: 1569178
[TBL] [Abstract][Full Text] [Related]
24. Plasma LH-HCG, 17 -estradiol, estrone and progesterone monitoring around ovulation and subsequent nidation.
Thomas K; De Hertogh R; Pizarro M; Van Exter C; Ferin J
Int J Fertil; 1973; 18(2):65-73. PubMed ID: 4353919
[TBL] [Abstract][Full Text] [Related]
25. Administration of human luteinizing hormone (hLH) to macaques after follicular development: further titration of LH surge requirements for ovulatory changes in primate follicles.
Zelinski-Wooten MB; Hutchison JS; Chandrasekher YA; Wolf DP; Stouffer RL
J Clin Endocrinol Metab; 1992 Aug; 75(2):502-7. PubMed ID: 1639951
[TBL] [Abstract][Full Text] [Related]
26. Changes in the binding of human chorionic gonadotrophin/luteinizing hormone, follicle-stimulating hormone and prolactin to human corpora lutea during the menstrual cycle and pregnancy.
McNeilly AS; Kerin J; Swanston IA; Bramley TA; Baird DT
J Endocrinol; 1980 Dec; 87(3):315-25. PubMed ID: 6778944
[TBL] [Abstract][Full Text] [Related]
27. Corpora lutea induced by gonadotrophin-releasing hormone treatment of anoestrous Welsh Mountain ewes: reduced sensitivity to luteinizing hormone in vivo and to chorionic gonadotrophin in vitro.
Bramley TA; Stirling D; Menzies GS; Baird DT
Reproduction; 2005 Jan; 129(1):61-73. PubMed ID: 15615899
[TBL] [Abstract][Full Text] [Related]
28. Effect of postovulatory treatment with a luteinizing hormone-releasing hormone analog on the plasma level of progesterone in women.
Koyama T; Ohkura T; Kumasaka T; Saito M
Fertil Steril; 1978 Nov; 30(5):549-52. PubMed ID: 363461
[TBL] [Abstract][Full Text] [Related]
29. Norplant implants: the mechanism of contraceptive action.
Segal SJ; Alvarez-Sanchez F; Brache V; Faundes A; Vilja P; Tuohimaa P
Fertil Steril; 1991 Aug; 56(2):273-7. PubMed ID: 1906407
[TBL] [Abstract][Full Text] [Related]
30. Daily serum choriogonadotropin concentrations in early human gestation.
Adejuwon CA; Alvarez F; Segal SJ; Faundes A
Int J Gynaecol Obstet; 1984 Apr; 22(2):125-9. PubMed ID: 6145636
[TBL] [Abstract][Full Text] [Related]
31. Luteal phase support with hCG does not improve fecundity rate in human menopausal gonadotropin-stimulated cycles.
Keenan JA; Moghissi KS
Obstet Gynecol; 1992 Jun; 79(6):983-7. PubMed ID: 1579327
[TBL] [Abstract][Full Text] [Related]
32. Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization.
Beckers NG; Laven JS; Eijkemans MJ; Fauser BC
Hum Reprod; 2000 Jan; 15(1):43-9. PubMed ID: 10611186
[TBL] [Abstract][Full Text] [Related]
33. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropin-releasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment.
Beckers NG; Macklon NS; Eijkemans MJ; Ludwig M; Felberbaum RE; Diedrich K; Bustion S; Loumaye E; Fauser BC
J Clin Endocrinol Metab; 2003 Sep; 88(9):4186-92. PubMed ID: 12970285
[TBL] [Abstract][Full Text] [Related]
34. Serum follicle-stimulating and luteinizing hormone and progesterone in single and multiple gestations following induction of ovulation.
Fogel M; Rubin BL; Ossowski R
Am J Obstet Gynecol; 1972 Mar; 112(5):629-39. PubMed ID: 5059593
[TBL] [Abstract][Full Text] [Related]
35. Human chorionic gonadotrophin luteal support overcomes luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles.
Peñarrubia J; Balasch J; Fábregues F; Creus M; Casamitjana R; Ballescá JL; Puerto B; Vanrell JA
Hum Reprod; 1998 Dec; 13(12):3315-8. PubMed ID: 9886506
[TBL] [Abstract][Full Text] [Related]
36. Restoration of the gonadotrophin response to LH-RH and oestrogen administration in patients after molar abortion.
Miyake A; Aono T; Tanizawa O; Kurachi H; Kurachi K
Acta Endocrinol (Copenh); 1979 May; 91(1):30-5. PubMed ID: 222100
[TBL] [Abstract][Full Text] [Related]
37. The luteal phase after ovulation induction with human menopausal gonadotropin and one versus two doses of a gonadotropin-releasing hormone agonist.
Corson SL; Batzer FR; Gocial B; Maislin G
Fertil Steril; 1993 Jun; 59(6):1251-6. PubMed ID: 8495774
[TBL] [Abstract][Full Text] [Related]
38. Recovery of corpus luteum function after prolonged deprivation from gonadotrophin stimulation.
Weissman A; Loumaye E; Shoham Z
Hum Reprod; 1996 May; 11(5):943-9. PubMed ID: 8671368
[TBL] [Abstract][Full Text] [Related]
39. Presence of elevated circulating levels of LH during the pre-menstrual period in some copper IUD users and the possibility of their confusion with hCG.
Dattatreyamurty B; Joshi J; Mehta S; Virkar KD; Sheth AR
Contraception; 1979 Mar; 19(3):213-21. PubMed ID: 455978
[TBL] [Abstract][Full Text] [Related]
40. Comparison of leuprolide acetate and human chorionic gonadotropin for the induction of ovulation in clomiphene citrate-stimulated cycles.
Scott RT; Bailey SA; Kost ER; Neal GS; Hofmann GE; Illions EH
Fertil Steril; 1994 May; 61(5):872-9. PubMed ID: 8174724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
